For Patients

Multiple sclerosis (MS)

There is still no cure for MS, but there are treatments for initial attacks, medications and therapies to improve symptoms, and recently developed drugs to slow the worsening of the disease. These new drugs have been shown to reduce the number and severity of relapses and to delay the long-term progression of MS. These treatments may include injectable steroids, oral steroids, and plasma exchanges as a secondary option in certain types of MS. In addition, drugs called disease modulators and immunomodulators are available to reduce relapses in patients with relapsing MS. called disease modulating drugs and immunomodulator medications impact the immune system to treat patients with relapsing MS.

Treatments

  • Corticosteroids
  • Immune Globulin Therapy
  • Immune Modulators
  • Plasma Exchange

More Information

please visit the Multiple Sclerosis Association of America at https://mymsaa.org/

Products We Offer

Immune Globulin Therapy

Corticosteroids

Contact CSI Pharmacy for more information on Corticosteroids.

Ampyra

Avonex

Copaxone

Corticosteroids

Extavia

Gilenya

Immune Globulin Therapy

Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity. Containing antibodies against a broad spectrum of bacteria and viruses, IVIG is administered intravenously and is used primarily to treat three categories of illnesses: primary immune deficiency diseases, autoimmune diseases and certain neurological disorders.

  • Bivigam
    ADMA Biologics
  • Gammagard S/D
    Takeda
  • Gammagard Liquid
    Takeda
  • Gammaked
    Kedrion
  • Gamunex-C
    Grifols
  • Octagam 5%
    Octapharma
  • Octagam 10%
    Octapharma
  • Privigen
    CSL Behring
  • Panzyga
    Pfizer

Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity. Containing antibodies against a broad spectrum of bacteria and viruses, SCIG is administered subcutaneously and is approved to treat primary immune deficiencies and chronic inflammatory demyelinating polyneuropathy. It is also in clinical trials for autoimmune diseases.

  • Cutaquig
    Takeda
  • Gammagard Liquid
    Takeda
  • Gammaked
    Kedrion
  • Gamunex-C
    Grifols
  • Hizentra
    CSL Behring
  • HyQvia
    Takeda
  • Xembify
    Grifols

Ribif